| Placebo | 0.6 mg sCT | 0.8 mg sCT | p-value |
---|---|---|---|---|
Females | Â | Â | Â | Â |
sCTX-I (ng/ml) | 0.758 (0.536-1.073) | 0.669 (0.503-0.891) | 0.555 (0.378-0.817) | 0.09 |
uCTX-II (ng/mmol) | 303 (161-570) | 410 (268-626) | 293 (192-449) | 0.21 |
Males | Â | Â | Â | Â |
sCTX-I (ng/ml) | 0.539 (0.413-0.704) | 0.588 (0.353-0.981) | 0.504 (0.340-0.747) | 0.64 |
uCTX-II (ng/mmol) | 278 (200-387) | 256 (159-411) | 263 (153-455) | 0.91 |